Clinical Trial Update: Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of Vilaprisan in patients with uterine fibroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Vilaprisan (vilaprisan)

Snippet

Sponsor: Bayer | Conditions: Leiomyoma | Phase 2 | Status: COMPLETED